GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hansa Biopharma AB (OSTO:HNSA) » Definitions » 5-Year Yield-on-Cost %

Hansa Biopharma AB (OSTO:HNSA) 5-Year Yield-on-Cost % : 0.00 (As of May. 31, 2024)


View and export this data going back to 2007. Start your Free Trial

What is Hansa Biopharma AB 5-Year Yield-on-Cost %?

Hansa Biopharma AB's yield on cost for the quarter that ended in Mar. 2024 was 0.00.


The historical rank and industry rank for Hansa Biopharma AB's 5-Year Yield-on-Cost % or its related term are showing as below:



OSTO:HNSA's 5-Year Yield-on-Cost % is not ranked *
in the Biotechnology industry.
Industry Median: 1.8
* Ranked among companies with meaningful 5-Year Yield-on-Cost % only.

Competitive Comparison of Hansa Biopharma AB's 5-Year Yield-on-Cost %

For the Biotechnology subindustry, Hansa Biopharma AB's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hansa Biopharma AB's 5-Year Yield-on-Cost % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Hansa Biopharma AB's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Hansa Biopharma AB's 5-Year Yield-on-Cost % falls into.



Hansa Biopharma AB 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Hansa Biopharma AB is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

Hansa Biopharma AB  (OSTO:HNSA) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Hansa Biopharma AB 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of Hansa Biopharma AB's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


Hansa Biopharma AB (OSTO:HNSA) Business Description

Traded in Other Exchanges
Address
Scheelevagen 22, Lund, SWE, 223 63
Hansa Biopharma AB is a biopharmaceutical company that develops immunomodulatory treatments for enabling transplantations and rare immunoglobulin G (IgG)-mediated autoimmune conditions, transplant rejection, and cancer. The company's product candidate, imlifidase, is an antibody-cleaving enzyme being developed to enable kidney transplantation in sensitized patients and further developed for use in other organ and tissue transplantation as well as acute autoimmune indications. It operates in Sweden, other European countries, and the U.S. The group generates the majority of its revenue from product sales.

Hansa Biopharma AB (OSTO:HNSA) Headlines

No Headlines